Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer (UK TACT2; CRUK/05/19): quality of life results from a multicentre, phase 3, open-label, randomised, controlled trial
| Autor: | Velikova, Galina *, Morden, James P, Haviland, Joanne S, Emery, Charlotte, Barrett-Lee, Peter, Earl, Helena, Bloomfield, David, Brunt, Adrian Murray, Canney, Peter, Coleman, Robert, Verrill, Mark, Wardley, Andrew, Bertelli, Gianfilippo, Ellis, Paul, Stein, Rob, Bliss, Judith M, Cameron, David |
|---|---|
| Zdroj: | In The Lancet Oncology December 2023 24(12):1359-1374 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|